Drugs Archives - Page 34 of 67

KHN’s ‘What The Health?’: How Will We Reopen The Economy?

The politics of COVID-19 are pretty polarized, but health experts across the ideological spectrum agree: The U.S. will need more robust testing before it’s safe to relax social-distancing requirements. Meanwhile, President Donald Trump, Congress and the nation’s governors continue to spar over who should be responsible for what. Kimberly Leonard of Business Insider, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

April 16, 2020

With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’

The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.

By Michelle Andrews

April 16, 2020

COVID-19

‘You Pray That You Got The Drug.’ Ailing Couple Gambles On Trial For COVID-19 Cure

Josie and George Taylor of Everett, Washington, are two of the first people in the U.S. to recover from novel coronavirus infections after joining a clinical trial for the antiviral drug remdesivir.

By JoNel Aleccia

April 6, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

April 3, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

March 27, 2020

COVID-19

Why Hoarding Of Hydroxychloroquine Needs To Stop

Six states — Idaho, Louisiana, Nevada, North Carolina, Ohio and Texas — have taken steps to limit inappropriate prescriptions for the medicine and preserve supplies for patients who take it for lupus and rheumatoid arthritis.

By Martha Bebinger, WBUR

March 25, 2020

Pharma Cash To Congress

Senators Who Led Pharma-Friendly Patent Reform Also Prime Targets For Pharma Cash

Three senators on a revived subcommittee received more than $100,000 each from drugmakers.

By Emmarie Huetteman

March 24, 2020

COVID-19

Mask Shortage Straps Pharmacists Who Need Them To Keep Medicines Pure

Fifteen percent of hospital pharmacists who prepare injectable drugs are going without the protective masks they typically use or are using substitutes for masks.

By Christina Jewett and Sydney Lupkin, NPR News

March 20, 2020

Heart Association Puts Halt To Bayer’s Giant Displays Of Baby Aspirin

After Kaiser Health News’ questions, the association tells the aspirin maker to take down display bins at Walmart pharmacies that gave a false impression that the over-the-counter drug is recommended for everyone to prevent heart attacks.

By Phil Galewitz

March 10, 2020

Colorado Forges Ahead On A New Model For Health Care While Nation Waits

Since gaining control of the House, Senate and governor’s office, Colorado Democrats are pushing an aggressive health care agenda. With measures to create a public insurance option, welcome drug importation, lower drug prices, curtail surprise billing and cap insulin copays, the state is becoming a likely model for health policies at the federal level.

By Markian Hawryluk

Feb. 28, 2020

Letters to the Editor

Readers And Tweeters Dive Into Debate Over ‘Medicare For All’

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

Feb. 28, 2020

COVID-19

As The Coronavirus Spreads, Americans Lose Ground Against Other Health Threats

Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.

By Liz Szabo

Feb. 26, 2020

Congressional Candidates Go Head-To-Head On Health Care — Again

The California Democratic members of Congress who flipped seven Republican seats two years ago made health care a major campaign issue, criticizing their opponents for voting to repeal the Affordable Care Act. As the Democrats defend their seats in this year’s elections, they are coming back to health care — but the issues are different.

By Ana B. Ibarra

Feb. 24, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Feb. 21, 2020

KHN & PolitiFact HealthCheck

Scalpels Out: Democrats Make Slashing Attacks On Health Care Plans

Candidates’ tough health policy talk strayed far from hope for unity.

By Emmarie Huetteman, Victoria Knight, and Shefali Luthra

Feb. 20, 2020

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

Feb. 14, 2020

Podcast

KHN’s ‘What The Health?’: Live from D.C. With Rep. Donna Shalala

President Donald Trump’s proposed budget includes billions of dollars in health spending cuts, Congress gets back to work on surprise medical bills, and health care remains a top issue for the 2020 Democratic presidential candidates. Rep. Donna Shalala (D-Fla.), a former Health and Human Services secretary, joins the panel at a special taping before a live audience in Washington, D.C. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more.

Feb. 13, 2020

COVID-19

To Fight Chinese Outbreak, Doctors Deploy Drugs Targeting HIV, Malaria And Ebola

Chinese doctors and public health officials are turning to a variety of drugs as they seek an effective treatment for patients sickened by the novel coronavirus. The evidence behind some of these medicines is flimsy, researchers acknowledge, but human trials are the only way to know whether these drugs work.

By Carmen Heredia Rodriguez

Feb. 13, 2020